Abbott Laboratories (NYSE:ABT – Get Free Report) was downgraded by equities researchers at StockNews.com from a “strong-buy” ...

The company's Q3 profit increased 16 per cent year-on-year (Y-o-Y) to Rs 360.78 crore as compared to Rs 310.98 crore ...

StockNews.com upgraded shares of Abbott Laboratories (NYSE:ABT – Free Report) from a buy rating to a strong-buy rating in a ...

One cupcake won't kill you,' 'I'm going to get diabetes just looking at that,' 'That person doesn't look like they have diabetes.' New survey results and a film released today by Abbott highlight how ...

Abbott India jumped 6.17% to Rs 27,756.50 after the company's net profit increased 16.01% to Rs 360.78 crore in Q3 FY25 as against Rs 310.98 crore posted in Q3 FY24.

4 Abbott's other technologies span the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 ...

Its current CEO is Miles White. Abbott is now comprised of four equally-sized businesses – diagnostics, medical devices, nutritionals and branded generic pharmaceuticals. According to its ...

Despite challenges, ongoing innovation and awareness are fueling market growth, with both branded and generic antibiotics ...

MTG Aetherdrift cards focus on a few major things: vehicles, speed, and vehicles again. However, somehow, the best cards are ...

nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries. Abbott will live-webcast its fourth-quarter earnings conference call through its ...

Introduction to Digital Health and WellnessThe digital health and wellness industry is experiencing significant growth as healthcare increasingly incorporates technology to improve the quality, ...